Skip to main content
Top
Published in: Current Diabetes Reports 3/2010

01-06-2010

Postpartum Screening Following GDM: How Well Are We Doing?

Authors: Kelly J. Hunt, Sarah L. Logan, Deborah L. Conway, Jeffrey E. Korte

Published in: Current Diabetes Reports | Issue 3/2010

Login to get access

Abstract

Once diagnosed with gestational diabetes mellitus (GDM), a woman has a sevenfold increased risk of developing type 2 diabetes relative to women who do not have diabetes during pregnancy. In addition, up to one third of women with GDM have overt diabetes, impaired fasting glucose, or impaired glucose tolerance identified during postpartum glucose screening completed within 6 to 12 weeks. Therefore, the American Diabetes Association, the World Health Organization, and the American College of Obstetricians and Gynecologists currently recommend postpartum glucose screening following GDM. However, despite this recommendation, in many settings the majority of women with GDM fail to return for postpartum glucose testing. Studies conducted to date have not comprehensively examined the health care system, the physician, or the patient determinants of successful screening. These studies are required to help develop standard clinical procedures that enable and encourage all women to return for postpartum glucose screening following GDM.
Literature
1.
go back to reference Hunt KJ, Schuller KL: The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007, 34:173–199, vii.CrossRefPubMed Hunt KJ, Schuller KL: The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007, 34:173–199, vii.CrossRefPubMed
2.
go back to reference Golden SH, Bennett WL, Baptist-Roberts K, et al.: Antepartum glucose tolerance test results as predictors of type 2 diabetes mellitus in women with a history of gestational diabetes mellitus: a systematic review. Gend Med 2009, 6(Suppl 1):109–122.CrossRefPubMed Golden SH, Bennett WL, Baptist-Roberts K, et al.: Antepartum glucose tolerance test results as predictors of type 2 diabetes mellitus in women with a history of gestational diabetes mellitus: a systematic review. Gend Med 2009, 6(Suppl 1):109–122.CrossRefPubMed
3.
go back to reference Baptiste-Roberts K, Barone BB, Gary TL, et al.: Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review. Am J Med 2009, 122:207–214.e4.CrossRef Baptiste-Roberts K, Barone BB, Gary TL, et al.: Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review. Am J Med 2009, 122:207–214.e4.CrossRef
4.
go back to reference •• Bellamy L, Casas JP, Hingorani AD, Williams D: Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009, 373:1773–1779. This study is a recent meta-analysis that reports a sevenfold increased risk of developing type 2 diabetes in women who had a pregnancy with GDM relative to women who did not have diabetes during pregnancy.CrossRefPubMed •• Bellamy L, Casas JP, Hingorani AD, Williams D: Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009, 373:1773–1779. This study is a recent meta-analysis that reports a sevenfold increased risk of developing type 2 diabetes in women who had a pregnancy with GDM relative to women who did not have diabetes during pregnancy.CrossRefPubMed
5.
go back to reference Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25:1862–1868.CrossRefPubMed Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25:1862–1868.CrossRefPubMed
6.
go back to reference Kjos SL, Peters RK, Xiang A, et al.: Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 1995, 44:586–591.CrossRefPubMed Kjos SL, Peters RK, Xiang A, et al.: Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes 1995, 44:586–591.CrossRefPubMed
7.
go back to reference Lobner K, Knopff A, Baumgarten A, et al.: Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006, 55:792–797.CrossRefPubMed Lobner K, Knopff A, Baumgarten A, et al.: Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006, 55:792–797.CrossRefPubMed
8.
go back to reference Peters RK, Kjos SL, Xiang A, Buchanan TA: Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996, 347:227–230.CrossRefPubMed Peters RK, Kjos SL, Xiang A, Buchanan TA: Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 1996, 347:227–230.CrossRefPubMed
9.
go back to reference Schaefer-Graf UM, Buchanan TA, Xiang AH, Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol 2002, 186:751–756.CrossRefPubMed Schaefer-Graf UM, Buchanan TA, Xiang AH, Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus. Am J Obstet Gynecol 2002, 186:751–756.CrossRefPubMed
10.
go back to reference Dawson SI: Glucose tolerance in pregnancy and the long-term risk of cardiovascular disease. Diabetes Res Clin Pract 2009, 85:14–19.CrossRefPubMed Dawson SI: Glucose tolerance in pregnancy and the long-term risk of cardiovascular disease. Diabetes Res Clin Pract 2009, 85:14–19.CrossRefPubMed
11.
go back to reference Retnakaran R, Qi Y, Connelly PW, et al.: Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 2010, 95:670–677.CrossRefPubMed Retnakaran R, Qi Y, Connelly PW, et al.: Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 2010, 95:670–677.CrossRefPubMed
12.
go back to reference Retnakaran R, Shah BR: Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 2009, 181:371–376.PubMed Retnakaran R, Shah BR: Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study. CMAJ 2009, 181:371–376.PubMed
13.
go back to reference Conway DL, Langer O: Effects of new criteria for type 2 diabetes on the rate of postpartum glucose intolerance in women with gestational diabetes. Am J Obstet Gynecol 1999, 181:610–614.CrossRefPubMed Conway DL, Langer O: Effects of new criteria for type 2 diabetes on the rate of postpartum glucose intolerance in women with gestational diabetes. Am J Obstet Gynecol 1999, 181:610–614.CrossRefPubMed
14.
go back to reference Hunt KJ, Conway DL: Who returns for postpartum glucose screening following gestational diabetes mellitus? Am J Obstet Gynecol 2008, 198:404.e1–404.e6.CrossRef Hunt KJ, Conway DL: Who returns for postpartum glucose screening following gestational diabetes mellitus? Am J Obstet Gynecol 2008, 198:404.e1–404.e6.CrossRef
15.
go back to reference Retnakaran R, Qi Y, Sermer M, Connelly PW, et al.: Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care 2008, 31:2026–2031.CrossRefPubMed Retnakaran R, Qi Y, Sermer M, Connelly PW, et al.: Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care 2008, 31:2026–2031.CrossRefPubMed
16.
go back to reference Greenberg LR, Moore TR, Murphy H: Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 1995, 86:97–101.CrossRefPubMed Greenberg LR, Moore TR, Murphy H: Gestational diabetes mellitus: antenatal variables as predictors of postpartum glucose intolerance. Obstet Gynecol 1995, 86:97–101.CrossRefPubMed
17.
go back to reference Kjos SL, Buchanan TA, Greenspoon JS, et al.: Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months post partum. Am J Obstet Gynecol 1990, 163(1 Pt 1):93–98.PubMed Kjos SL, Buchanan TA, Greenspoon JS, et al.: Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months post partum. Am J Obstet Gynecol 1990, 163(1 Pt 1):93–98.PubMed
18.
go back to reference Almario CV, Ecker T, Moroz LA, et al.: Obstetricians seldom provide postpartum diabetes screening for women with gestational diabetes. Am J Obstet Gynecol 2008, 198:528.e1–528.e5.CrossRef Almario CV, Ecker T, Moroz LA, et al.: Obstetricians seldom provide postpartum diabetes screening for women with gestational diabetes. Am J Obstet Gynecol 2008, 198:528.e1–528.e5.CrossRef
19.
go back to reference Dietz PM, Vesco KK, Callaghan WM, et al.: Postpartum screening for diabetes after a gestational diabetes mellitus-affected pregnancy. Obstet Gynecol 2008, 112:868–874.PubMed Dietz PM, Vesco KK, Callaghan WM, et al.: Postpartum screening for diabetes after a gestational diabetes mellitus-affected pregnancy. Obstet Gynecol 2008, 112:868–874.PubMed
20.
go back to reference Ferrara A, Peng T, Kim C: Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: a report from the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2009, 32:269–274.CrossRefPubMed Ferrara A, Peng T, Kim C: Trends in postpartum diabetes screening and subsequent diabetes and impaired fasting glucose among women with histories of gestational diabetes mellitus: a report from the Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 2009, 32:269–274.CrossRefPubMed
21.
go back to reference Kim C, Tabaei BP, Burke R, et al.: Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health 2006, 96:1643–1648.CrossRefPubMed Kim C, Tabaei BP, Burke R, et al.: Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. Am J Public Health 2006, 96:1643–1648.CrossRefPubMed
22.
go back to reference Kwong S, Mitchell RS, Senior PA, Chik CL: Postpartum diabetes screening: adherence rate and the performance of fasting plasma glucose versus oral glucose tolerance test. Diabetes Care 2009, 32:2242–2244.CrossRefPubMed Kwong S, Mitchell RS, Senior PA, Chik CL: Postpartum diabetes screening: adherence rate and the performance of fasting plasma glucose versus oral glucose tolerance test. Diabetes Care 2009, 32:2242–2244.CrossRefPubMed
23.
go back to reference Russell MA, Phipps MG, Olson CL, et al.: Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 2006, 108:1456–1462.PubMed Russell MA, Phipps MG, Olson CL, et al.: Rates of postpartum glucose testing after gestational diabetes mellitus. Obstet Gynecol 2006, 108:1456–1462.PubMed
24.
go back to reference Smirnakis KV, Chasan-Taber L, Wolf M, et al.: Postpartum diabetes screening in women with a history of gestational diabetes. Obstet Gynecol 2005, 106:1297–1303.PubMed Smirnakis KV, Chasan-Taber L, Wolf M, et al.: Postpartum diabetes screening in women with a history of gestational diabetes. Obstet Gynecol 2005, 106:1297–1303.PubMed
25.
go back to reference World Health Organization: Report of a WHO Consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization. Department of Noncommunicable Disease Surveillance; 1999. World Health Organization: Report of a WHO Consultation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization. Department of Noncommunicable Disease Surveillance; 1999.
26.
go back to reference Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus [no authors listed]. Diabetes Care 1997, 20:1183–1197. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus [no authors listed]. Diabetes Care 1997, 20:1183–1197.
27.
go back to reference Genuth S, Alberti KG, Bennett P, et al.: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160–3167.CrossRefPubMed Genuth S, Alberti KG, Bennett P, et al.: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160–3167.CrossRefPubMed
28.
go back to reference American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 32(Suppl 1):S62–S67.CrossRef American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 32(Suppl 1):S62–S67.CrossRef
29.
go back to reference Metzger BE, Buchanan TA, Coustan DR, et al.: Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007, 30(Suppl 2):S251–S260.CrossRefPubMed Metzger BE, Buchanan TA, Coustan DR, et al.: Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 2007, 30(Suppl 2):S251–S260.CrossRefPubMed
30.
go back to reference •• Committee on Obstetric Practice: ACOG Committee Opinion No. 435: postpartum screening for abnormal glucose tolerance in women who had gestational diabetes mellitus. Obstet Gynecol 2009, 113:1419–1421. This ACOG committee opinion was published following the release of results from the HAPO (Hyperglycemia and Adverse Pregnancy Outcomes) study. HAPO is a large prospective study demonstrating the correlation between increasing hyperglycemia and increased rates of fetal overgrowth. •• Committee on Obstetric Practice: ACOG Committee Opinion No. 435: postpartum screening for abnormal glucose tolerance in women who had gestational diabetes mellitus. Obstet Gynecol 2009, 113:1419–1421. This ACOG committee opinion was published following the release of results from the HAPO (Hyperglycemia and Adverse Pregnancy Outcomes) study. HAPO is a large prospective study demonstrating the correlation between increasing hyperglycemia and increased rates of fetal overgrowth.
31.
go back to reference American Diabetes Association: Standards of medical care in diabetes—2009. Diabetes Care 2009, 32(Suppl 1):S13–S61.CrossRef American Diabetes Association: Standards of medical care in diabetes—2009. Diabetes Care 2009, 32(Suppl 1):S13–S61.CrossRef
32.
go back to reference Baker AM, Brody SC, Salisbury K, et al.: Postpartum glucose tolerance screening in women with gestational diabetes in the state of North Carolina. N C Med J 2009, 70:14–19.PubMed Baker AM, Brody SC, Salisbury K, et al.: Postpartum glucose tolerance screening in women with gestational diabetes in the state of North Carolina. N C Med J 2009, 70:14–19.PubMed
33.
go back to reference Gabbe SG, Gregory RP, Power ML, et al.: Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol 2004, 103:1229–1234.PubMed Gabbe SG, Gregory RP, Power ML, et al.: Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol 2004, 103:1229–1234.PubMed
34.
go back to reference Morrison MK, Collins CE, Lowe JM: Postnatal testing for diabetes in Australian women following gestational diabetes mellitus. Aust N Z J Obstet Gynaecol 2009, 49:494–498.CrossRefPubMed Morrison MK, Collins CE, Lowe JM: Postnatal testing for diabetes in Australian women following gestational diabetes mellitus. Aust N Z J Obstet Gynaecol 2009, 49:494–498.CrossRefPubMed
35.
go back to reference Ogonowski J, Miazgowski T: The prevalence of 6 weeks postpartum abnormal glucose tolerance in Caucasian women with gestational diabetes. Diabetes Res Clin Pract 2009, 84:239–244.CrossRefPubMed Ogonowski J, Miazgowski T: The prevalence of 6 weeks postpartum abnormal glucose tolerance in Caucasian women with gestational diabetes. Diabetes Res Clin Pract 2009, 84:239–244.CrossRefPubMed
36.
go back to reference Clark HD, Graham ID, Karovitch A, Keely EJ: Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. Am J Obstet Gynecol 2009, 200:634.e1–634.e7.CrossRef Clark HD, Graham ID, Karovitch A, Keely EJ: Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. Am J Obstet Gynecol 2009, 200:634.e1–634.e7.CrossRef
37.
go back to reference Chiasson JL, Josse RG, Gomis R, et al.: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002, 359:2072–2077.CrossRefPubMed Chiasson JL, Josse RG, Gomis R, et al.: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002, 359:2072–2077.CrossRefPubMed
38.
go back to reference Gerstein HC, Yusuf S, Bosch J, et al.: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006, 368:1096–1105.CrossRefPubMed Gerstein HC, Yusuf S, Bosch J, et al.: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006, 368:1096–1105.CrossRefPubMed
39.
go back to reference Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393–403.CrossRefPubMed Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393–403.CrossRefPubMed
40.
go back to reference Pan XR, Li GW, Hu YH, et al.: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997, 20:537–544.CrossRefPubMed Pan XR, Li GW, Hu YH, et al.: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997, 20:537–544.CrossRefPubMed
41.
go back to reference Tuomilehto J, Lindstrom J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343–1350.CrossRefPubMed Tuomilehto J, Lindstrom J, Eriksson JG, et al.: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343–1350.CrossRefPubMed
Metadata
Title
Postpartum Screening Following GDM: How Well Are We Doing?
Authors
Kelly J. Hunt
Sarah L. Logan
Deborah L. Conway
Jeffrey E. Korte
Publication date
01-06-2010
Publisher
Current Science Inc.
Published in
Current Diabetes Reports / Issue 3/2010
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-010-0110-x

Other articles of this Issue 3/2010

Current Diabetes Reports 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.